HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia
Clinical trial NCT00524667 · TERMINATED
Trial details
- NCT number
- NCT00524667
- Sponsor
- CancerCare Manitoba
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2011-07-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.